Filing Details

Accession Number:
0000899243-22-019397
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-24 19:00:23
Reporting Period:
2022-05-20
Accepted Time:
2022-05-24 19:00:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1635088 Roivant Sciences Ltd. ROIV Pharmaceutical Preparations (2834) 981173944
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1750094 Matthew Gline C/O Roivant Sciences Ltd.
11-12 St. James'S Square, Ste 1, 3Rd Fl
London X0 SW1Y 4LB
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2022-05-20 139,791 $3.70 1,264,657 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.